NuvOx Pharma: Funding, Investors & Team (Oct 2026)
Located in Tucson, Arizona, NuvOx Pharma is a biotechnology business that is creating a first-of-its-kind oxygen therapy to cure fatal diseases where hypoxia is a factor. Seven different indications have seen a therapeutic impact in more than 30 animal investigations. The company is getting ready to conduct a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure after Phase Ib/II clinical trials in oncology and stroke showed safety and evidence of efficacy (AHRF) Diane Fairfield painted the image for the cover.
NuvOx Pharma has raised $1.1M across 1 funding round on record, the most recent an undisclosed round of $1.1M announced in Feb 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NuvOx Pharma Company Profile and Key Stats
Latest funding round on record: Feb 2023.
NuvOx Pharma Funding Rounds
NuvOx Pharma Founders and Leadership Team
Contact details for the NuvOx Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →NuvOx Pharma Funding Compared to Other Biotechnology Startups
NuvOx Pharma's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NuvOx Pharma in Biotechnology and Tucson
Companies Similar to NuvOx Pharma
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
NuvOx Pharma Funding FAQs
What does NuvOx Pharma do?
Located in Tucson, Arizona, NuvOx Pharma is a biotechnology business that is creating a first-of-its-kind oxygen therapy to cure fatal diseases where hypoxia is a factor. Seven different indications have seen a therapeutic impact in more than 30 animal investigations. The company is getting ready to conduct a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure after Phase Ib/II clinical trials in oncology and stroke showed safety and evidence of efficacy (AHRF) Diane Fairfield painted the image for the cover.
How much funding has NuvOx Pharma raised?
NuvOx Pharma has raised $1.1M across 1 round on record. The most recent is an undisclosed round of $1.1M announced in Feb 2023.
When did NuvOx Pharma last raise funding?
NuvOx Pharma's most recent funding round on record is an undisclosed round of $1.1M, announced in Feb 2023.
Who is the CEO of NuvOx Pharma?
Evan Unger is listed as CEO at NuvOx Pharma.
Where is NuvOx Pharma headquartered?
NuvOx Pharma is based in Tucson, Arizona, United States.
How many employees does NuvOx Pharma have?
NuvOx Pharma is in the 11-50 employee band.
How does NuvOx Pharma's funding compare to other Biotechnology startups?
NuvOx Pharma's latest round of $1.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's NuvOx Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NuvOx Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.